NCT04575961
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04575961
Title Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer (PERCEPTION)
Acronym PERCEPTION
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors North Eastern German Society of Gynaecological Oncology
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.